American Academy of Ophthalmology Meeting

American Academy of Ophthalmology Meeting

November 22, 2013
1 min read

Small-incision lenticule extraction largely predictable, speaker says

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

NEW ORLEANS — Patient- and surgery-related parameters had a minimal effect on the safety, efficacy and predictability of small-incision lenticule extraction for myopia, according to a study presented here.

Jesper Hjortdal, MD, presented results during the Journal of Refractive Surgery’s Hot, Hotter and Hottest: Late Breaking News session on Refractive Subspecialty Day preceding the American Academy of Ophthalmology meeting.

Hjortdal’s presentation was based on a paper that was awarded the Journal of Refractive Surgery’s annual Waring Medal.

“We can say that safety and efficacy were, from a clinical perspective, found to be independent of spherical treatment attempts up to 10 D of myopia and were not influenced in any degree by the age of the patients,” Hjortdal said. “In terms of predictability, I think we can conclude that the treatment nomogram needs only minor adjustments.”

The prospective clinical quality control study included 670 eyes of 335 patients with up to 10 D of myopia and up to 2 D of astigmatism who underwent the ReLEx smile procedure (Carl Zeiss Meditec) and were followed for 3 months.

Results showed that spherical equivalent refraction was within 1 D of targeted values in 93% of eyes and within 0.5 D in 70%. Mean undercorrection was 0.25 D. Undercorrection was predicted by increasing age and steeper corneal curvature. However, these factors had a minimal effect , Hjortdal said.

Visual acuity of 20/25 or better was attained in 85% of eyes targeted for emmetropia.

Four percent of eyes gained two or more lines of vision, and 1.5% lost two or more lines at 3 months.

Disclosure: Hjortdal receives lecture fees from Carl Zeiss Meditec.